" /> Nephrotic syndrome, type 2 - CISMeF





Preferred Label : Nephrotic syndrome, type 2;

Symbol : NPHS2;

CISMeF acronym : NPHS2; SRN1;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : SRN1; Nephrotic syndrome, steroid-resistant, autosomal recessive;

Description : Steroid-resistant nephrotic syndrome type 2 is an autosomal recessive disorder characterized clinically by childhood onset of proteinuria, hypoalbuminemia, hyperlipidemia, and edema. Kidney biopsies show nonspecific histologic changes such as minimal change, focal segmental glomerulosclerosis (FSGS), and diffuse mesangial proliferation. The disorder is resistant to steroid treatment and progresses to end-stage renal failure in the first or second decades (summary by Fuchshuber et al., 1996). Some patients show later onset of the disorder (Tsukaguchi et al., 2002). For a general phenotypic description and a discussion of genetic heterogeneity of nephrotic syndrome and FSGS, see NPHS1 (256300).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the podocin gene (NPHS2, 604766.0001);

Laboratory abnormalities : Hyperlipidemia; Hypoalbuminemia;

Prefixed ID : #600995;

Détails


Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.